AgeX Therapeutics Inc. (was merged with Biotechnology Serina Therapeutics (NYSE: SER) on 27/04/2024) (AGE)
New Form 8-K - Serina Therapeutics, Inc. Filed: 2025-09-09 AccNo: 0001708599-25-000108 Size: 252 KB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
There are no comments here yet...